Dianomi Therapeutics
2017
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Corporate
LATEST DEAL TYPE
$3M
LATEST DEAL AMOUNT
1
INVESTORS
Description
Owner and operator of a biopharmaceutical company focused on developing treatments for inflammatory diseases, initially targeting osteoarthritis (OA). The company's mineral coated microparticle (MCM) technology has the ability to provide sustained release delivery of active biologics, an issue many traditional drug delivery systems struggle with, providing patients with improved, sustained-release delivery of active biologics.
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 504 South Rosa Road
- Suite 200
- Madison, WI 53719
- United States
+1 (303) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Dianomi Therapeutics’s full profile, request a free trial.
Dianomi Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Corporate | 04-Feb-2019 | $3M | 00.000 | Completed | Pre-Clinical Trials | |
| 1. Angel (individual) | 25-Jan-2019 | 00000 | 00000 | Completed | Pre-Clinical Trials |
Dianomi Therapeutics Competitors (29)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CrossBeta Biosciences | Formerly VC-backed | Utrecht, Netherlands | 00 | 00.00 | 000000&0 | 00.00 |
| 0000000 0000000000 | Venture Capital-Backed | Bozeman, MT | 0 | 000.00 | 000000000000 | 000.00 |
| 0000000 0000000 | Venture Capital-Backed | Switzerland | 00.000 | 00000000000 | 00.000 | |
| 000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
| 00000 | Formerly PE-Backed | Paris, France | 00 | 00000 | 00000000000 | 00000 |
Dianomi Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Ligand Pharmaceuticals | Corporation | Minority | 000 0000 | 000000 0 |
Dianomi Therapeutics Executive Team (6)
You’re viewing 5 of 6 executives. Get the full list »Dianomi Therapeutics Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Barry Kurokawa | Dianomi Therapeutics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Carter Cliff Ph.D | Self | Co-Founder & Board Member | 000 0000 | |
| Kurtis Knapp Ph.D | Dianomi Therapeutics | Co-Founder & Board Member | 000 0000 | |
| Martin Ostrowski | Self | Co-Founder, Chief Operating Officer, General Counsel & Board Member | 000 0000 | |
| William Murphy Ph.D | Dianomi Therapeutics | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |